CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

CVRX Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

CVRx, Inc.NASDAQ: CVRX

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue growth accelerates

Q1 FY2026 revenue of $14.77M rose 19.6% year over year, ahead of the +11.7% change in trailing-twelve-month revenue. Sequentially, it fell 7.8% from the prior quarter. Over 3 fiscal years it compounded at +36.1% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 5 analysts of $58.96M (+4.1%) for the fiscal year ending Dec 2026, a slowdown from the +10.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.77M-7.8% QoQ
Last fiscal yearDec 2025
$56.65M+10.4% YoY
LTMMar 2026
$59.07M+11.7% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.6%+14.4%-5.2 pp
1 year+10.4%+4.1%-6.4 pp
3-year CAGR+36.1%+10.3%-25.8 pp
5-year CAGR+16.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
56.65M USD
Year-over-year change
+10.4%
4-year CAGR
+44.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How CVRX compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +11.7% is the 6th highest of 10, against a peer median of +15.4%.
  • Over three fiscal years its annual growth of +36.1% compares with a peer median of +14.9%.
CVRX Competitors
Revenue for CVRX and competitors
Company Period LTM YoY 3-year CAGR
VMDViemed Healthcare, Inc.LTM Mar 2026$286.57M USD+23.1%+24.9%
CERSCerus CorporationLTM Mar 2026$222.79M USD+20.3%+8.4%
QTRXQuanterix CorporationLTM Mar 2026$144.87M USD+8.2%+9.5%
SGHTSight Sciences, Inc.LTM Mar 2026$79.55M USD+1.8%+2.7%
CVRXCVRx, Inc.LTM Mar 2026$59.07M USD+11.7%+36.1%
MASS908 Devices Inc.LTM Mar 2026$57.8M USD+2.2%+6.2%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$44.33M USD+22.5%+38.1%
SENSSenseonics Holdings, Inc.LTM Mar 2026$40.71M USD+71.9%+29.1%
PRQRProQR Therapeutics N.V.LTM Mar 2026€13.44M EUR-29.2%+62.0%
NNOXNano-X Imaging Ltd.LTM Dec 2025$13.02M USD+15.4%+14.9%
Peer median (excluding CVRX) —+15.4%+14.9%

Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.04M22.47M39.3M51.29M56.65M
Cost of Revenue3.64M5M6.26M8.33M8.31M
Gross Profit9.4M17.47M33.04M42.96M48.34M
Gross Margin72.1%77.8%84.1%83.8%85.3%
Research & Development7.5M9.95M11.63M11.13M11.13M
Selling, General & Admin27.86M50.05M64.51M91.32M88.47M
Operating Expenses35.36M60M76.14M102.45M99.61M
Depreciation & Amortization168K412K522K619K756K
EBITDA(40.6M)(40.74M)(38.73M)(54.89M)(46.74M)
EBITDA Margin-311.4%-181.3%-98.6%-107.0%-82.5%
Operating Income(25.97M)(42.53M)(43.1M)(59.49M)(51.27M)
Operating Margin-199.2%-189.3%-109.7%-116.0%-90.5%
Interest Income00000
Interest Expense2.22M165K1.8M4.4M5.83M
Other Income / Expenses(17.02M)1.21M2.05M(420K)(2.06M)
Income Before Tax(42.99M)(41.32M)(41.05M)(59.91M)(53.32M)
Pre-Tax Margin-329.8%-183.9%-104.5%-116.8%-94.1%
Income Tax Expense91K109K147K55K(18K)
Net Income(43.08M)(41.43M)(41.2M)(59.97M)(53.31M)
Net Margin-330.5%-184.4%-104.8%-116.9%-94.1%
EPS (Basic)(2.11)(2.02)(1.99)(2.65)(2.04)
EPS (Diluted)(2.11)(2.02)(1.99)(2.65)(2.04)
Weighted Avg Shares20.72M20.51M20.7M22.6M26.08M
Weighted Avg Shares (Diluted)20.72M20.53M20.75M22.6M26.08M

CVRx, Inc.

NASDAQ:CVRX

Intrinsic Alpha fair value

Locked

Current Price

$2.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.